Rare and unusual... Or are they? Less commonly diagnosed encephalopathies associated with systemic disease

Seminars in Neurology

Volumn 29, Issue 2, 2009, Pages 136-153

  Weathers, Allison L ^a   Lewis, Steven L ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Pancreatic encephalopathy; Pellagra encephalopathy; Wernicke's encephalopathy

Indexed keywords

ADRENALIN; AZATHIOPRINE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CEFEPIME; CHLORAMPHENICOL; ETHIONAMIDE; FLUOROURACIL; GLYCERYL TRINITRATE; IFOSFAMIDE; ISONIAZID; LACTULOSE; LORAZEPAM; MAGNESIUM; MERCAPTOPURINE; NARCOTIC AGENT; NEOMYCIN; NICOTINAMIDE; NICOTINIC ACID; ORAL ANTIDIABETIC AGENT; PETHIDINE; PHENOBARBITAL; PHENYTOIN; PUROMYCIN; PYRAZINAMIDE; PYRIDOXINE; RIFAXIMIN; THIAMINE; UNINDEXED DRUG; VITAMIN B GROUP;

ABSENCE OF SIDE EFFECTS; ACUTE PANCREATITIS; AGITATED DEPRESSION; AGITATION; ALCOHOLISM; ANXIETY DISORDER; APHASIA; ATAXIA; BACTERIAL INFECTION; BLEEDING; BONE MARROW SUPPRESSION; BRAIN DISEASE; BRAIN TOXICITY; CATATONIA; CENTRAL PONTINE MYELINOLYSIS; CHRONIC KIDNEY FAILURE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; COMA; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CRANIAL NEUROPATHY; DELIRIUM; DELIRIUM TREMENS; DIALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DISORIENTATION; DIZZINESS; DRUG CLEARANCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; ELECTROLYTE DISTURBANCE; FAT EMBOLISM; FLAPPING TREMOR; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HEMIPARESIS; HEMODIALYSIS; HEMORRHAGIC CYSTITIS; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERURICEMIA; HYPOALBUMINEMIA; HYPONATREMIA; INSOMNIA; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER INJURY; LOW DRUG DOSE; LYMPHOMA; META ANALYSIS; METABOLIC ENCEPHALOPATHY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PANCREAS DISEASE; PANCREATIC ENCEPHALOPATHY; PELLAGRA; PERSONALITY DISORDER; PHYSICIAN; PRIORITY JOURNAL; RESUSCITATION; REVIEW; RISK FACTOR; SEIZURE; SEPSIS; SEPTIC ENCEPHALOPATHY; SIDE EFFECT; SOFT TISSUE CANCER; SOLID TUMOR; SOMNOLENCE; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; SYSTEMIC DISEASE; THIAMINE DEFICIENCY; TONIC CLONIC SEIZURE; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME; TREATMENT RESPONSE; UREMIA; UREMIC ENCEPHALOPATHY; URINE INCONTINENCE; VITAMIN SUPPLEMENTATION; WERNICKE ENCEPHALOPATHY; CENTRAL NERVOUS SYSTEM DISEASE; RARE DISEASE;

CENTRAL NERVOUS SYSTEM DISEASES; HEPATIC ENCEPHALOPATHY; HUMANS; PANCREATIC DISEASES; PELLAGRA; RARE DISEASES; UREMIA; WERNICKE ENCEPHALOPATHY;

EID: 67549107513     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0029-1213734     Document Type: Review

References (132)

1. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-721 (Pubitemid 34183979)
2. Munoz SJ. Hepatic encephalopathy. Med Clin North Am 2008;92:795-812
3. Lockwood AH. Hepatic encephalopathy. In: Aminoff MJ, ed. Neurology and General Medicine. 4th ed. Philadelphia, PA: Churchill Livingstone; 2008:265-279
4. Morgan MY, Blei A, Grüngreiff K, et al. The treatment of hepatic encephalopathy. Metab Brain Dis 2007;22:389-405
5. Bleck TP. Neurological disorders in the intensive care unit. Semin Respir Crit Care Med 2006;27:201-209 (Pubitemid 44061623)
6. De Deyn PP, Saxena VK, Abts H, et al. Clinical and pathophysiological aspects of neurological complications in renal failure. Acta Neurol Belg 1992;92(4):191-206
7. Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg 2004;107:1-16 (Pubitemid 39556672)
8. Burn DJ, Bates D. Neurology and the kidney. J Neurol Neurosurg Psychiatry 1998;65:810-821
9. Aminoff MJ. Neurological dysfunction and kidney disease. In: Aminoff MJ, ed. Neurology and General Medicine. 4th ed. Philadelphia, PA: Churchill Livingstone; 2008:327-346
10. Riggs JE. Neurological manifestations of electrolyte disturbances. Neurol Clin 2002;20(1):227-239
11. Spinazzé S, Schrijvers D. Metabolic emergencies. Crit Rev Oncol Hematol 2006;58:79-89
12. Rothermich NO, von Haam E. Pancreatic encephalopathy. J Clin Endocrinol 1941;1:872-881
13. Estrada RV, Moreno J, Martinez E, et al. Pancreatic encephalopathy. Acta Neurol Scand 1979;59:135-139
14. Sun GH, Yang YS, Lui QS, Cheng LF, Huang XS. Pancreatic encephalopathy and Wernicke encephalopathy in association with acute pancreatitis: a clinical study. World J Gastroenterol 2006;12(26):4224-4227
15. Ding X, Liu CA, Gong JP, Li SW. Pancreatic encephalopathy in 24 patients with severe acute pancreatitis. Hepatobiliary Pancreat Dis Int 2004;3(4):608-611 (Pubitemid 39561978)
16. Johnson DA, Tong NT. Pancreatic encephalopathy. South Med J 1977;70(2):165-167
17. Ruggieri RM, Lupo I, Piccoli F. Pancreatic encephalopathy: a 7-year follow-up case report and review of the literature. Neurol Sci 2002;23:203-205 (Pubitemid 35345496)
18. Bourgeois JA, Fakhri D. Pancreatic encephalopathy with prolonged delirium. Psychosomatics 2007;48(4):352-354
19. Boon P, de Reuck J, Achten E, de Bleecker J. Pancreatic encephalopathy: a case report and review of the literature. Clin Neurol Neurosurg 1991;93(2):137-141
20. Menza MA, Murray GB. Pancreatic encephalopathy. Biol Psychiatry 1989;25:781-784
21. Bartha P, Shifrin E, Levy Y. Pancreatic encephalopathy - a rare complication of a common disease. Eur J Intern Med 2006;17:382 (Pubitemid 44080533)
22. Sharf B, Bental E. Pancreatic encephalopathy. J Neurol Neurosurg Psychiatry 1971;34:357-361
23. Ohkubo T, Shiojiri T, Matsunaga T. Severe diffuse white matter lesions in a patient with pancreatic encephalopathy. J Neurol 2004;251(4):476-478 (Pubitemid 38501309)
24. Guardia SN, Bilbao J, Murray D, Warren RE, Sweet J. Fat embolism in acute pancreatitis. Arch Pathol Lab Med 1989;113(5):503-506
25. Vogel FS. Cerebral demyelination and focal visceral lesions in a case of acute hemorrhagic pancreatitis. AMA Arch Pathol 1951;52(4):355-362
26. Vogel FS. Demyelinization induced in living rabbits by means of a lipolytic enzyme preparation. J Exp Med 1951;93(4):297-304
27. Edmondson HA, Fields IA. Relation of calcium and lipids to acute pancreatic necrosis: report of fifteen cases, in one of which fat embolism occurred. Arch Intern Med 1942;69:177-194
28. Sjaastad O, Gjessing SL, Ritland S, Blichfeldt P, Sandnes K. Chronic relapsing pancreatitis encephalopathy with disturbance of consciousness and CSF amino acid aberration. J Neurol 1979;220(2):83-94 (Pubitemid 9125298)
29. Thomson AD, Cook CC, Guerrini I, Sheedy D, Harper C, Marshall EJ. Wernicke's encephalopathy revisited. Translation of the case history section of the original manuscript by Carl Wernicke 'Lehrbuch der Gehirnkrankheiten fur Aerzte and Studirende' (1881) with a commentary. Alcohol Alcohol 2008;43(2):174-179
30. Pearce JMS. Wernicke-Korsakoff encephalopathy. Eur Neurol 2008;59:101-104
31. Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 2007;6:442-455 (Pubitemid 46551868)
32. Victor M, Adams RD, Collins GH. The Wernicke- Korsakoff Syndrome and Related Neurologic Disorders Due to Alcoholism and Malnutrition. 2nd ed. Philadelphia, PA: FA Davis Company; 1989
33. Cravioto H, Korein J, Silberman J. Wernicke's encephalopathy. A clinical and pathological study of 28 autopsied cases. Arch Neurol 1961;4:510-519
34. Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry 1986;49:341-345 (Pubitemid 16116131)
35. Cook CC, Hallwood PM, Thomson AD. B vitamin deficiency and neuropsychiatric syndromes in alcohol misuse. Alcohol Alcohol 1998;33(4):317-333 (Pubitemid 28380025)
36. Harper C. The incidence of Wernicke's encephalopathy in Australia: a neuropathological study of 131 cases. J Neurol Neurosurg Psychiatry 1983;46:593-598
37. de Wardener HE, Lennox B. Cerebral beriberi (Wernicke's encephalopathy): review of 52 cases in a Singapore prisoner-of-war hospital. Lancet 1947;1:11-17
38. Caine D, Halliday GM, Kril JJ, Harper CG. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry 1997;62:51-60 (Pubitemid 27047441)
39. Wallis WE, Willoughby E, Baker P. Coma in the Wernicke-Korsakoff syndrome. Lancet 1978;2(8086):400-401
40. Torvik A. Brain lesions in alcoholics: neuropathological observations. Acta Med Scand 1987;(suppl 717):47-54 (Pubitemid 17123743)
41. Thomson AD, Cook CC, Guerrini I, Sheedy D, Harper C, Marshall EJ. Wernicke's encephalopathy: 'Plus ça change, plus c'est a mème chose'. Alcohol Alcohol 2008;43(2):180-186
42. 1 avitaminosis in pigeons with hemorrhagic polioencephalitis occurring in chronic alcoholism in man. Am J Pathol 1940;16:61-69
43. Thomson AD, Marshall EJ. The natural history and pathophysiology of Wernicke's encephalopathy and Korsakoff psychosis. Alcohol Alcohol 2006;41(2):151-158
44. Cook CCH, Thomson AD. B-complex vitamins in the prophylaxis and treatment of Wernicke-Korsakoff syndrome. Br J Hosp Med 1997;57(9):461-465 (Pubitemid 127799782)
45. Thomson AD, Jeyasingham MD, Pratt OE, Shaw GK. Nutrition and alcoholic encephalopathies. Acta Med Scand Suppl 1987;(717):55-65
46. Harper C. Thiamine (vitamin B1) deficiency and associated brain damage is still common throughout the world and prevention is simple and safe!. Eur J Neurol 2006;13:1078-1082 (Pubitemid 44434312)
47. Todd KG, Hazell AS, Butterworth RF. Alcohol-thiamine interactions: an update on the pathogenesis of Wernicke encephalopathy. Addict Biol 1999;4:261-272 (Pubitemid 29385272)
48. Thomson AD, Cook CC, Touquet R, Henry JA. The Royal College of Physicians report on alcohol: guidelines for managing Wernicke's encephalopathy in the accident and emergency department. Alcohol Alcohol 2002;37(6):513-521 (Pubitemid 35385883)
49. Meyer O. The Wernicke syndrome: with special reference to manic syndromes associated with hypothalamic lesions. J Neurol Neurosurg Psychiatry 1944;7:66-75
50. Spruill SC, Kuller JA. Hyperemesis gravidarum complicated by Wernicke's encephalopathy. Obstet Gynecol 2002;99(5): 875-877 (Pubitemid 34442402)
51. Salas-Salvadó J, García-Lorda P, Cuatrecasas G, et al. Wernicke's syndrome after bariatric surgery. Clin Nutr 2000;19(5):371-373
52. Juhasz-Pocsine K, Rudnicki SA, Archer RL, Harik SI. Neurological complications of gastric bypass surgery for morbid obesity. Neurology 2007;68:1843-1850 (Pubitemid 46791400)
53. Wrenn KD, Slovis CM. Is intravenous thiamine safe? Am J Emerg Med 1992;10(2):165
54. Bae SJ, Lee HK, Lee JH, Choi CG, Suh DC. Wernicke's encephalopathy: atypical manifestation at MR imaging. AJNR Am J Neuroradiol 2001;22:1480-1482 (Pubitemid 32862258)
55. Koontz DW, Fernandes Filho JA, Sagar SM, Rucker JC. Video: Wernicke encephalopathy. Neurology 2004;63(2):394
56. Day E, Bentham B, Callaghan R, Kuruvilla T, George S. Thiamine for Wernicke-Korsakoff syndrome in people at risk from alcohol abuse. Cochrane Database Syst Rev 2004;1:CD004033
57. Rajakumar K. Pellagra in the United States: a historical perspective. South Med J 2000;93(3):272-277 (Pubitemid 30159753)
58. Lanska DJ. Stages in the recognition of epidemic pellagra in the United States: 1865-1960. Neurology 1996;47:829-834
59. Spivak JL, Jackson DL. Pellagra: an analysis of 18 patients and a review of the literature. Johns Hopkins Med J 1977;140:295-309 (Pubitemid 8131331)
60. Figueroa WG, Sargent F, Imperiale L, et al. Lack of avitaminosis among alcoholics: its relation to fortification of cereal products and the general nutritional status of the population. J Clin Nutr 1953;1(3):179-199
61. Kertesz SG. Pellagra in 2 homeless men. Mayo Clin Proc 2001;76:315-318
62. Jarrett P, Duffill M, Oakley A, Smith A. Pellagra, azathioprine and inflammatory bowel disease. Clin Exp Dermatol 1997;22:44-45 (Pubitemid 27368408)
63. Lyon VB, Fairley JA. Anticonvulsant-induced pellagra. J Am Acad Dermatol 2002;46:597-599
64. Isaac S. The "gauntlet" of pellagra. Int J Dermatol 1998; 37:599
65. MacDonald A, Forsyth A. Nutritional deficiencies and the skin. Clin Exp Dermatol 2005;30:388-390
66. Jagielska G, Tomaszewicz-Libudzic CE, Brzozowska A. Pellagra: a rare complication of anorexia nervosa. Eur Child Adolesc Psychiatry 2007;16:417-420
67. Itami A, Ando I, Kukita A, Nagai K. Pellagra associated with amyloidosis secondary to multiple myeloma. Br J Dermatol 1997;137:829 (Pubitemid 27496212)
68. Delgado-Sanchez L, Godkar D, Niranjan S. Pellagra: rekindling of an old flame. Am J Ther 2008;15:173-175
69. Okan G, Yaylaci S, Alzafer S. Pellagra: will we see it more frequently? J Eur Acad Dermatol Venereol 2008; June 26 (Epub ahead of print). Available at: http://www3.interscience. wiley.com/journal/120748368\abstract. Accessed August 3, 2008
70. Ishii N, Nishihara Y. Pellagra among chronic alcoholics: clinical and pathological study of 20 necropsy cases. J Neurol Neurosurg Psychiatry 1981;44:209-215 (Pubitemid 11113194)
71. Spies TD, Aring CD, Gelperin J, Bean WB. The mental symptoms of pellagra: their relief with nicotinic acid. Am J Med Sci 1938;196(4):461-475
72. Piercecchi-Marti MD, Pélissier-Alicot AL, Leonetti G, Tervé JP, Cianfarani F, Pellissier JF. Pellagra: a rare disease observed in a victim of mental and physical abuse. Am J Forensic Med Pathol 2004;25(4):342-344 (Pubitemid 39602096)
73. Serdaru M, Hausser-Hauw C, Laplane D, et al. The clinical spectrum of alcoholic pellagra encephalopathy: a retrospective analysis of 22 cases studied pathologically. Brain 1988; 111:829-842 (Pubitemid 18200620)
74. Ishii N, Nishihara Y. Pellagra encephalopathy among tuberculous patients: its relation to isoniazid therapy. J Neurol Neurosurg Psychiatry 1985;48:628-634 (Pubitemid 15026236)
75. Zimmerman HM, Cohen LH, Gildea EF. Pellagra in association with chronic alcoholism. Arch Neurol Psychiatry 1934;31:290-309
76. Jolliffe N, Bowman KM, Rosenblum LA, Fein HD. Nicotinic acid deficiency encephalopathy. JAMA 1941;114:307-312
77. Jolliffe N. Treatment of neuropsychiatric disorders with vitamins. JAMA 1941;117:1496-1502
78. Victor M. Alcoholic dementia. Can J Neurol Sci 1994;21:88-99
79. Langworthy OR. Lesions of the central nervous system characteristic of pellagra. Brain 1931;54:291-302
80. Pitsavas S, Andreou C, Bascialla F, Bozikas VP, Karavatos A. Pellagra encephalopathy following B-complex vitamin treatment without Niacin. Int J Psychiatry Med 2004;34(1): 91-95 (Pubitemid 38812510)
81. Spies TD, DeWolf HF. Observations on the etiological relationship of severe alcoholism to pellagra. Am J Med Sci 1933;186(4):521-525
82. Lu JY, Yu CL, Wu MZ. Pellagra in an immunocompetent patient with cytomegalovirus colitis. Am J Gastroenterol 2001;96(3):932-934 (Pubitemid 32240774)
83. Wallengren J, Thelin I. Pellagra-like skin lesions associated with Wernicke's encephalopathy in a heavy wine drinker. Acta Derm Venereol 2002;82:152-154 (Pubitemid 34596700)
84. Lishman WA. Cerebral disorder in alcoholism: syndromes of impairment. Brain 1981;104:1-20 (Pubitemid 12184874)
85. Pandharipande P, Shintani A, Peterson J, et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006;104:21-26
86. Alagiakrishnan K, Wiens CA. An approach to drug induced delirium in the elderly. Postgrad Med J 2004;80:388-393 (Pubitemid 38961859)
87. Marcantonio ER, Juarez G, Goldman L, et al. The relationship of postoperative delirium with psychoactive medications. JAMA 1994;272(19):1518- 1522 (Pubitemid 24340794)
88. Barradell LB, Bryson HM. Cefepime: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1994;47(3):471-505 (Pubitemid 24087111)
89. Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for SENTRY antimicrobial surveillance program, 1997-1999. Clin Infect Dis 2001;32(suppl 2):S114-S132 (Pubitemid 32424266)
90. Diekema DJ, Pfaller MA, Jones RN, et al. Survey of bloodstream infections due to Gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY antimicrobial surveillance program, 1997. Clin Infect Dis 1999;29(3):595-607
91. Neu HC. Safety of cefepime: a new extended-spectrum parenteral cephalosporin. Am J Med 1996;100(suppl 6A): 68S-75S (Pubitemid 26243597)
92. Lam S, Gomolin IH. Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review. Pharmacotherapy 2006;26(8):1169-1174 (Pubitemid 44167825)
93. Jallon P, Fankhauser L, Du Pasquier R, et al. Severe but reversible encephalopathy associated with cefepime. Neurophysiol Clin 2000;30:383-386 (Pubitemid 32009987)
94. Fishbain JT, Monahan TP, Canonico MM. Cerebral manifestations of cefepime toxicity in a dialysis patient. Neurology 2000;55(1):1756-1757
95. Dixit S, Kurle P, Buyan-Dent L, Sheth RD. Status epilepticus associated with cefepime. Neurology 2000;54:2153-2155
96. Martínez-Rodríguez JE, Barriga FJ, Santamaria J, et al. Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure. Am J Med 2001;111: 115-119 (Pubitemid 32728403)
97. Fernández-Torre JL, Martínez-Martínez M, González- Rato J, et al. Cephalosporin-induced nonconvulsive status epilepticus: clinical and electroencephalographic features. Epilepsia 2005;46(9):1550-1552 (Pubitemid 43919496)
98. Barbey F, Bugnon D, Wauters JP. Severe neurotoxicity of cefepime in uremic patients. Ann Intern Med 2001;135(11): 1011 (Pubitemid 33131630)
99. De Silva DA, Pan AB, Lim SH. Cefepime-induced encephalopathy with triphasic waves in three Asian patients. Ann Acad Med Singapore 2007;36(6):450-451 (Pubitemid 47234400)
100. Chatellier D, Jourdain M, Mangalaboyi J, et al. Cefepimeinduced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure. Intensive Care Med 2002;28:214-217 (Pubitemid 34293837)
101. Capparelli FJ, Diaz MF, Hlavnika A, et al. Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function. Neurology 2005;65(11):1840 (Pubitemid 43754433)
102. Maganti R, Jolin D, Rishi D, Biswas A. Nonconvulsive status epilepticus due to cefepime in a patient with normal renal function. Epilepsy Behav 2006;8:312-314 (Pubitemid 43103866)
103. Fishman RA. Blood-brain and CSF barriers to penicillin and related organic acids. Arch Neurol 1966;15:113-124
104. Abanades S, Nolla J, Rodríguez-Campello A, Pedro C, Valls A, Farré M. Reversible coma secondary to cefepime neurotoxicity. Ann Pharmacother 2004;38:606-608 (Pubitemid 38352223)
105. Fernández-Torre JL. Cefepime and cefixime-induced encephalopathy in a patient with normal renal function. (Letter to Editor)Neurology 2006;67(2):367 (Pubitemid 44305443)
106. Capparelli FJ, Diaz MF, Hlavnika A, Wainsztein NA, Leiguarda R, Del Castillo ME. Cefepime and cefiximeinduced encephalopathy in a patient with normal renal function. (Reply from authors)Neurology 2006;67(2): 367 (Pubitemid 44305443)
107. De Sarro A, Ammendola D, Zappala M, Grasso S, De Sarro GB. Relationship between structure and convulsant properties of some β-lactam antibiotics following intracerebroventricular microinjection in rats. Antimicrob Agents Chemother 1995;39(1):232-237
108. A receptor blockade in convulsions induced by cephalosporins. Neuropharmacology 2003;45: 304-314 (Pubitemid 36836127)
109. Streck EL, Comim CM, Barichello T, Quevedo J. The septic brain. Neurochem Res 2008;33(11):2171-2177
110. Dakdouki GK, Al-Awar GN. Cefepime-induced encephalopathy. Int J Infect Dis 2004;8:59-61
111. Jackson GD, Berkovic SF. Ceftazidime encephalopathy: absence status and toxic hallucinations. J Neurol Neurosurg Psychiatry 1992;55(4):333-334
112. Kiangkitiwan B, Doppalapudi A, Fonder M, Solberg K, Bohner B. Levofloxacin-induced delirium with psychotic features. Gen Hosp Psychiatry 2008;30:381-383
113. Isaacson SH, Carr J, Rowan AJ. Ciprofloxacin-induced complex partial status epilepticus manifesting as an acute confusional state. Neurology 1993;43:1619-1621 (Pubitemid 23230562)
114. Park IS, Lee HJ, Lee YS, Hwang JS, Lee MS. Ifosfamideinduced encephalopathy with or without using methylene blue. Int J Gynecol Cancer 2005;15:807-810 (Pubitemid 41783085)
115. David KA, Picus J. Evaluating risk factors for the development of ifosfamide encephalopathy. Am J Clin Oncol 2005; 28(3):277-280 (Pubitemid 40800480)
116. Patel PN. Methylene blue for management of ifosfamideinduced encephalopathy. Ann Pharmacother 2006;40: 299-303 (Pubitemid 43269862)
117. Pelgrims J, De Vos F, Van den Brande J, Schrijvers D, Prové A, Vermorken JB. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature. Br J Cancer 2000;82(2):291-294 (Pubitemid 30045372)
118. Buesa JM, García-Teijido P, Losa R, Fra J. Treatment of ifosfamide encephalopathy with intravenous thiamin. Clin Cancer Res 2003;9:4636-4637 (Pubitemid 37248425)
119. Simonian NA, Gilliam FG, Chiappa KH. Ifosfamide causes a diazepam-sensitive encephalopathy. Neurology 1993;43:2700-2702
120. Papadopoulos MC, Ceri Davies D, Moss RF, Tighe D, Bennett ED. Pathophysiology of septic encephalopathy: a review. Crit Care Med 2000;28(8):3019-3024
121. Young GB. Neurologic complications of systemic critical illness. Neurol Clin 1995;13(3):645-658
122. Bolton CF, Young GB, Zochodne DW. The neurological complications of sepsis. Ann Neurol 1993;33:94-100
123. Young GB, Bolton CF, Archibald YM, Austin TW, Wells GA. The electroencephalogram in sepsis-associated encephalopathy. J Clin Neurophysiol 1992;9(1):145-152
124. van der Helm-van Mil AH, van Vugt JPP, Lammers GJ, Harinck HI. Hypernatremia from a hunger strike as a cause of osmotic myelinosis. Neurology 2005;64(1):574-575 (Pubitemid 40189892)
125. Kleinschmidt-DeMasters BK, Rojiani AM, Filley CM. Central and extrapontine myelinolysis: then. . .and now. J Neuropathol Exp Neurol 2006;65(1):1-11 (Pubitemid 43755384)
126. Talbot M, Schemitsch EH. Fat embolism syndrome: history, definition, epidemiology. Injury 2006;37(S4):S3-S7 (Pubitemid 44399836)
127. Fabian TC. Unraveling the fat embolism syndrome. N Engl J Med 1993;329:961-963
128. Wang HD, Zheng JH, Deng CL, Liu QY, Yang SL. Fat embolism syndromes following liposuction. Aesthetic Plast Surg 2008;32(5):731-736
129. Jacobson DM, Terrence CF, Reinmuth OM. The neurologic manifestations of fat embolism. Neurology 1986;36(6):847-851
130. Hüfner K, Holtmannspötter M, Bürkle H, et al. Fat embolism syndrome as a neurologic emergency. Arch Neurol 2008;65(8):1124-1125
131. Van Besouw JP, Hinds CJ. Fat embolism syndrome. Br J Hosp Med 1989;42(4):304-311
132. Parizel PM, Demey HE, Veeckmans G, et al. Early diagnosis of cerebral fat embolism syndrome by diffusionweighted MRI (starfield pattern). Stroke 2001;32:2942-2944 (Pubitemid 33134494)